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PhylogenyPapillomaviruses play an important role in human cancer development, and have been isolated from a
number of animal malignancies. However, the association of papillomaviruses with tumors has been poorly
investigated in sheep. In this study, a novel ovine Papillomavirus, OaPV3, was cloned from sheep squamous
cell carcinoma. Unlike the already known ovine papillomaviruses, belonging to the Delta genus, OaPV3 lacks
the E5 open reading frame and maintains the conserved retinoblastoma motif in the E7 gene. OaPV3 infects
exclusively epithelial cells, and was found in skin of healthy sheep of geographically separated ﬂocks located
in Sardinia (Italy). This new virus is transcriptionally active in tumors and shares low homology with all the
other papillomaviruses, establishing a new genus. Taken together, the co-occurrence of OaPV3 and tumors, its
cell and tissue tropism, and its gene repertoire, suggests a role for this virus in development of sheep
squamous cell carcinoma.e Clinica Veterinaria Dell'Uni-
erinaria, Via Vienna 2, 07100
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Papillomaviruses (PVs) are a diverse group of small, non-
enveloped, double stranded DNA viruses that cause proliferations of
the stratiﬁed squamous epithelium of the skin and of the mucosa in a
wide variety of host species (Bernard et al., 2010; zur Hausen and de
Villiers, 1994). A large number of different PV types have been
genetically characterized and deﬁned as genotypes, most of them
being highly species-speciﬁc, and some being associated to deﬁned
degrees of pathogenicity (de Villiers et al., 2004; Van Ranst et al.,
1992). More than 100 human genotypes (HPVs) are implicated in
both benign (warts, papillomas or condylomas) andmalignant lesions
(zur Hausen, 2009). The Alpha genus contains predominantly mucosal
HPVs, among which HPV16 and HPV18 are involved in the
development of about two thirds of all cervical carcinomas world-
wide. Moreover, several cutaneous HPVs of the Beta genus (types 5, 8,
9, 12, 14, 15, 17, 19–25) and of the Nu genus (type 41), have been
frequently reported in association with squamous cell skin carcino-
mas of immunosuppressed but also of immunocompetent patients
(zur Hausen, 2009), and in patients with the rare hereditary diseaseepidermodysplasia verruciformis (Kim et al, 2010; Nuovo and Ishag,
2000). Similarly, several animal genotypes have been isolated from
canine, feline, rodents, primate, and bovine squamous cell carcinomas,
and from othermalignancies (see Table S1) (Borzacchiello et al., 2003;
Campo, 2002; Chambers et al., 2003; Munday et al., 2009; Nasir and
Campo, 2008; Yuan et al., 2007). Squamous cell carcinoma (SCC) is the
most common form of skin cancer in sheep (Ovis aries), and it has
been reported in Australia (Hawkins et al, 1981; Swan et al, 1984;
Tilbrook et al., 1992), South Africa (Tustin et al., 1982), France
(Lagadic et al., 1982), Spain (Méndez et al., 1997), Saudi Arabia
(Ramadan et al., 1991), and Brazil (Del Fava et al., 2001). Papilloma-
virus DNA was identiﬁed by means of “in situ” hybridization
techniques in pre-cancerous ear lesions (Trenﬁeld et al., 1990), and
in sheep perineal tumors (Tilbrook et al., 1992). Additionally,
papillomavirus particles were identiﬁed by electron microscopy in
pre-tumoral and tumoral lesions of ewes (Vanselow and Spradbrow,
1983). However, the two papillomavirus genotypes OaPV1 and OaPV2
isolated so far in sheep seem to associate only to ﬁbropapillomas and
have never been observed in precancerous lesions and skin tumors.
Based on these preliminary data, we hypothesized that unknown
epidermotropic ovine papillomaviruses (OaPVs) may exist, and that
they may be detected in cases of ovine SCC. Consequently, we
extracted DNA from cases of well differentiated ovine SCCs, and
ampliﬁed circular DNA by the recently described multiple-primed
rolling-circle ampliﬁcation (RCA) method, which has been shown to
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al., 2001; Rector et al, 2004; Rector et al, 2005). Indeed, papilloma-
virus-like DNA was ampliﬁed from two ovine SCCs, cloned, and
sequenced. Sequence determination and analysis resulted in the
detection and primary description of a third OaPV (OaPV3). The new
isolate meets the majority of criteria needed to declare detection of a
novel genus among the papillomaviruses (Bernard et al., 2010; de
Villiers et al., 2004). In situ hybridization combined to immunohis-
tochemistry revealed that OaPV3 infects exclusively epithelial cells.
Finally PCR and RT-PCR allowed establishing the presence of OaPV3 in
geographically separated ﬂocks and of OaPV3 early transcripts in
tumors, respectively.
Results
RCA, cloning and sequencing of the OaPV3 genome
DNA samples representative of 4 SCC biopsies were ampliﬁed
using multiply primed rolling circle ampliﬁcation (RCA). RCA
generates linear, double-stranded tandem-repeated copies of circular
template DNAs (Dean et al., 2001; Nelson et al., 2002). After
denaturation of circular DNA templates, exonuclease-protected
random hexamer primers anneal to the template DNA at multiple
sites, and are extended by a phi 29 DNA polymerase. When this DNA
polymerase reaches a downstream extended primer, strand displace-
ment occurs. Newly synthesized strands can subsequently be
available as targets for additional priming events, thus resulting in
exponential isothermal ampliﬁcation. The obtained double-stranded,
high molecular-weight, tandem-repeated copies of the template DNA
are then digested with a panel of restriction enzymes, and the
presence of a papillomavirus genome is established by the appearance
of a band (or multiple bands) consistent with the size of a
papillomavirus genome (about 7–8 kb) in agarose electrophoresis.
After digestion with a panel of restriction endonucleases, RCA
products obtained from 2 of the 4 SCCs generated an invariant pattern
consistent with the size of a papillomavirus genome (Fig. 1A). In
particular, EcoRI and StuI produced a single band of about 7.5 Kb.
Digestions with HindIII resulted in 3 DNA fragments of approximately
1, 2.1, and 4.2 kb, respectively. The use of NruI, MluI, and KpnI did notFig. 1. Rolling circle ampliﬁcation and restriction analyses. (A). ML: 1 kb DNA ladder; 1
to 6, RCA digestions withNruI,MluI, SacI, EcoRI, KpnI, HindIII, respectively; 7, undigested
RCA product. Production of Dig-labeled E6/E7 probes (B and C, respectively). ML,
100 bp DNA ladder; 1, digoxigenin-labeled probes; 2, unlabeled controls. Transcription
of OaPV3 E6 from sSCC (D). ML: 1 kb DNA ladder; ampliﬁcation of E6 from cDNA
generated by using: 1, primer OaPV3/E6/START, and 2, random hexamers; 3, DNase-
treated RNA extractions; 4, vendor positive control; 5, negative control; 6, Total OaPV3
DNA. Transcription of OaPV3 E7 from sSCC (E). ML: 1 kb DNA ladder; ampliﬁcation of E7
from cDNA generated by using: 1, primer OaPV3/E7/START, and 2, random hexamers;
3, DNase-treated RNA extractions; 4, vendor negative control; 5, vendor positive
control; 6, water; 7, Total OaPV3 DNA.result in the appearance of detectable DNA fragments. The restriction
pattern associatedwith the 2 SCC sampleswas compared to that of the
fully sequenced ovine papillomaviruses OaPV1 and OaPV2, obtained
in silico with the same restriction endonucleases (Table S2). Based on
RCA results, we hypothesized the presence of an unknown papillo-
mavirus in the 2 SCC samples. According to the guidelines for
Papillomavirus taxonomy (Bernard et al., 2010; de Villiers et al.,
2004), this putative novel papillomavirus was named OaPV3. The
7.5 Kb SacI fragments obtained from the 2 RCA-ampliﬁed SCC DNA
samples were successfully cloned into pUC19. When the two SCC
clones were independently sequenced by primer walking, a 100%
identity was observed, conﬁrming that both SCC carcinomas
contained the same virus. In order to establish that SacI was indeed
a single cutter of the OaPV3 genome, and to conﬁrm that the full
genome of OaPV3 was properly cloned into pUC19, a 0.8-kb region
surrounding the SacI site was ampliﬁed from SCC DNA and from a
non-digested RCA product obtained from the same sample. Compar-
ison of the nucleotide sequences obtained from the amplicons
resulted in 100% identity, conﬁrming that the complete OaPV3
genome was correctly cloned into pUC19 (data not shown).
The complete OaPV3 genome sequence
The complete nucleotide sequence of the Ovis aries papillomavirus
type 3 genome (OaPV3, GenBank accession number FJ796965) counts
7344 bp, and has a GC content of 46.8%. The OaPV3 genome contains
the classical PV major ORFs E6, E7, E1, E2, L2, L1. A putative E4 is also
present as a result of a spliced message. Notably, OaPV3 lacks the E5
ORF, which is constantly present in the ovine Papillomaviruses OaPV1
and OaPV2. The exact locations of the ORFs and comparisons with
related papillomaviruses are shown in Fig. 2 and Table 1, respectively.
The noncoding region (NCR)
The classic noncoding region, located between the stop codon of L1
and the start codon of E6, counts 635 bp in OaPV3 (nt 1 to 635). NCR
usually contains an E1 recognition site (E1BS) ﬂanked by two E2-
binding sites (E2BS), for binding of an E1/E2 complex in order to
activate the origin of replication. OaPV3 NCR contains 6 typical E2-
binding sites (E2BS) with the consensus sequence ACC-N6-GGT at nt
107–118, 152–163, 190–201, 234–245, 314–325, and 367–378.
We failed to locate an E1BS. A double polyadenylation signal
(AATAAATAAA, nt 7336–2) required for the processing of the L1
and L2 capsid mRNA transcript is present upstream of a CA
dinucleotide and of a G/T cluster. The OaPV3 NCR contains the tata
box (TATAAAT, nt 604–609) of the E6 promoter, located 25
nucleotides upstream the E6 start codon.
OaPV3 early region
The putative OaPV3 E6 contains two conserved zinc-binding
domains (C-X-X-C-X29-C-X-X-C), separated by 36 amino acids. The
E7 ORF contains one such zinc-biding domain and the conserved
retinoblastoma tumor suppressor binding domain (LYCDE). The E1
ORF codes for the largest OaPV3 protein (607 amino acids), and
contains the conserved ATP-binding site for the ATP dependent
helicase (GPSDTGKS) in its carboxy-terminal part. It also contains a
cyclin interaction RXL motif (the native KRRLF recruitment motif)
which mediates E1 interaction with and phosphorylation by cyclin/
Cdk complexes and is required for efﬁcient HPV replication in vivo
(Ma et al., 1999). Moreover, the open reading frame E4 was identiﬁed
as a result of a spliced message unifying the ﬁrst few codons of E1 (nt
1303–1315) with a downstream ORF in the +1 frame of the E2 ORF
(nt 3676–4013). Remarkably, the typical open reading frame E5 could
not be identiﬁed.
Fig. 2. Schematic representation of the OaPV3 genome. The genome is divided into three sections: early genes (Early region), late genes (Late region) and long control region (LCR).
Coding sequences from initiation to stop codon are shown as rectangles.
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The late region codes for the major (L1) and minor (L2) capsid
protein genes. Both L1 (KRRRK) and L2 (KKKRKKKR) contain a series
of arginine and lysine residues at their carboxy terminus, which
are likely to function as a nuclear localization signal. A double
polyadenylation signal (AATAAATAAA) for processing the early viral
mRNA transcript is present within the beginning of the L2 ORF (nt
4417–4426, 102 nt downstream the E2 stop codon), 20 nt upstream of
a CA dinucleotide.
Similarity with other papillomaviruses and phylogenetic analysis
The sequence similarity between OaPV3 and EdPV-1 (a malignant
cutaneous North American porcupine PV of the Sigmapapillomavirus;
GenBank accession number NC_006951), HPV-41 (a malignant
cutaneous PV of the Nupapillomavirus; NC_001354), OaPV1 (a
ﬁbropapilloma-associated ovine PV of the Deltapapillomavirus;
NC_001789), OaPV2 (a ﬁbropapilloma-associated ovine PV of the
Deltapapillomavirus; U83595), and HPV-16 (a prototype mucosal
high-risk PV of the Alphagenus; NC_001526), was investigated by
pairwise alignments of the corresponding ORFs and their proteins
(Table 1). Such alignment revealed that OaPV3 sequence shares only a
low degree of similarity with other PV sequences, slightly higher for
the PV of the Nu and Sigma genera. The highest similarity (51 to 55%)
was observed for the L1 ORF. This result places OaPV3 in a new PV
genus, since different genera of PV are deﬁned by sharing less than
60% nucleotide sequence identity in the L1 ORF (Bernard et al., 2010).
A neighbor-joining phylogenetic tree was constructed, based on a
concatenated E1/E2/L2/L1 nucleotide sequence alignment of OaPV3
and 70 PV-types of the different PV genera and species (Fig. 3).
Nucleotide sequence alignments, based on the corresponding amino
acid alignments, were constructed separately for the different ORFs.
Regions where an unambiguous alignment could be obtained were
included in one combined alignment of 1552 nucleotides (see
supplementary material, S3). The resulting neighbor-joining phylo-
genetic tree clusters the PVs in the different genera, according to the
new classiﬁcation of PV (Bernard et al., 2010; de Villiers et al., 2004).
In this tree, OaPV3 appears as a novel close-to-root papillomavirusTable 1
Percentage nucleotide (amino acid) identity of the different OaPV3 ORFs with the ORFs
of several related papillomaviruses.
OaPV3 ORF EdPV-1 HPV-41 OaPV1 OaPV2 HPV-16
E6 38 (19) 43 (23) 42 (20) 42 (21) 41 (19)
E7 30 (25) 36 (26) 40 (23) 39 (23) 47 (35)
E1 52 (49) 48 (40) 51 (37) 51 (37) 51 (38)
E2 47 (28) 46 (28) 46 (27) 47 (27) 46 (30)
L2 46 (29) 45 (28) 45 (24) 45 (22) 44 (26)
L1 55 (49) 55 (46) 51 (44) 53 (44) 53 (45)related to the Nu and Sigma genera, and weakly related to the
arctiodactyl papillomaviruses of the Delta genus. Maximum parsimo-
ny trees constructed by using the same nucleotide alignment were in
agreement with neighbor-joining trees (data not shown).
In situ hybridization
Slides were obtained from 4 SCC lesions and from normal skin of 4
sheep. The use of the L1 and E6 digoxigenated probes (Fig. 1B, C)
resulted in the presence of an OaPV3 speciﬁc nuclear signal in slides
derived from 2 of the 4 SCC samples (Fig. 4). These tumor DNA
samples were the same that tested positive to RCA and were the
source for OaPV3 isolation (see above). In particular, an OaPV3-
speciﬁc nuclear signal was observed in proliferating epithelium
invading the derma, where intercellular bridges of epithelial cell
and whorl pattern formation (keratin pearls) were evident. The
OaPV3 nuclear signal was only observed in the positive anti-pan-
cytokeratin cells, suggesting that exclusively epithelial cells were
infected by OaPV3. A positive signal was also observed in adjacent
normal skin tissue of the same samples/sheep (data not shown).
Detection of OaPV3 DNA in healthy sheep skin samples
A PCR targeting the L1 region of the OaPV3 genome was used to
investigate the presence of OaPV3 DNA in skin obtained from healthy
sheep sampled in ﬂocks where SCC was present (ﬂocks C, D), and in
ﬂocks where SCC was never observed (ﬂocks E, F). OaPV3 DNA was
detected in all ﬂocks, with a percentage of positive sheep per ﬂock
ranging from 10% to 30% (see Table S4). This result was consistent for
all three replicates of the 40 DNA samples, while liver DNA extractions
and negative PCR controls tested constantly negative. Three indepen-
dent replicates of the PCR assay originated the same result. Sequences
obtained from amplicons shared a 100% homology and matched the
corresponding region of OaPV3.
Detection of OaPV3 RNA transcripts in ovine SCCs
The presence of OaPV3 early transcripts in RNA extracted from the
two RCA-positive SCC was established by applying E6 and E7 speciﬁc
PCRs on cDNAs retrotranscribed independently with primers target-
ing the early region and with random hexamers. E6 and E7 speciﬁc
PCRs demonstrated the presence of early transcripts in RNA samples
extracted from both the SCC lesions (Fig. 1D, E). All cDNA replicates
obtained either with random examers or retrotranscribed with
primers targeting the early region of OaPV3 tested positive by E6
and E7 PCRs. Non-retrotranscribed DNase-treated tumor RNA extrac-
tions and sheep liver cDNA, used as negative controls for presence of
residual DNA, were always PCR-negative. Sequencing of PCR products
always resulted in sequences sharing 100% identity with the
corresponding region of OaPV3.
Fig. 3. Neighbor-joining phylogenetic tree, based on a 1552-bp combined concatenated E1/E2/L2/L1 nucleotide sequence alignment of OaPV3 and 70 other animal and human type
PVs. The numbers at the internal nodes represent the bootstrap support values, determined for 10,000 iterations with the neighbor-joining method. Only bootstrap probabilities
greater than 80% are shown.
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SCC is the second most common form of skin cancer in humans,
and has been frequently reported in different animal species, often in
association with papillomaviruses (Bernard et al., 2010; zur Hausen,
2009). In sheep, it develops in conjunction with solar injury, which is
heightened when animals ingest photosensitizing plants or are
subjected to Mules' operation and tail docking (Méndez et al.,
1997). Due to the high incidence recorded in some ﬂocks, and the
resulting decrease in yield and loss of income from the sale of
breeding animals, ovine SCC is of economic signiﬁcance in some parts
of the world. In Australia, it was responsible for more than one third of
all condemnations before slaughter (Hawkins et al., 1981). InMerinos,
12% of tumors have been observed to metastasize, mainly to the lung
but also to the regional lymph node (Ladds and Entwistle, 1977; Lloyd,
1961). SCC poses a direct threat to sheep, especially to those highly
selected for milk production, such as Sarda breed sheep, by
compromising the udders of ewes. Although it was demonstratedthat papillomaviruses play an important role in the development of
cervix cancer (zur Hausen, 2009), the association of papillomaviruses
with tumors has been poorly investigated in sheep. The two sheep
papillomavirus OaPV1 and OaPV2 identiﬁed to date belong to Delta
papillomavirus, and were isolated from healthy sheep. Papilloma-
viruses of the Delta genus share a ﬁbroblast cellular tropism, and lack
the canonical pRB-binding domain in the E7 ORF, features related to
the development of ﬁbropapillomas (Narechania et al., 2004). For
these reasons, OaPV1 and OaPV2 are poor candidates for a potential
role in the development of SCC, which is a tumor of epithelial origin.
On the other hand, epitheliotropic papillomaviruses have been
isolated from cases of SCC in species other than sheep. In this study,
we selected 4 cases of well differentiated SCC in sheep, and
investigated them for the presence of papillomaviruses. First, we
established the absence of OaPV1 and OaPV2 in the 4 tumors, by
applying PCR tests designed to amplify the L1, E6, and E5 of these
viruses (data not shown). Subsequently, we applied RCA combined to
restriction analyseswith a panel of endonucleases andwe obtained an
Fig. 4. Typical ﬁelds obtained when probing SCCs with the E6/L1 digoxigenated probes by in situ hybridization (left column). Top, middle: cordons of epithelial cells invading the
derma with nuclei positive to OaPV3. Bottom: keratin pearl in detail: OaPV3-positive nuclei of squamous cells. Right column: positive cytoplasmic immunoreactivity of epithelial
cells to anti-pan-cytokeratin. Same ﬁelds of in-situ hybridization.
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genome, from 2 of the 4 SCCs (Fig. 1A). This pattern differed from
the one calculated in silico for OaPV1 and OaPV2 (Table S2). The
genome of this novel Papillomavirus, which we named OaPV3, was
successfully cloned and fully sequenced. Unlike the Delta papilloma-
viruses OaPV1 and OaPV2, OaPV3 lacks an E5 gene and maintains the
conserved retinoblastoma tumor suppressor binding sequence motif
in E7. For these reasons, the OaPV3 genome does not meet the criteria
for ﬁbroblasts infection and ﬁbropapilloma development typical of
Arctiodactyl papillomaviruses, while its genes repertoire is reminis-
cent of the epitheliotropic human papillomavirus of the Beta genus.
Indeed, in-situ hybridization experiments conducted in tumors
conﬁrmed that OaPV3 infects exclusively epithelial cells, arranged
either in solid cords or nests forming often epithelial “pearls” in the
derma (Fig. 4).
Pairwise alignments of OaPV3 to selected Papilloma viruses
(Table 1) demonstrate that the OaPV3 sequence shares only a low
degree of similarity with other PVs. In particular, OaPV3 shares less
than 60% nucleotide sequence identity in the L1 ORF with any other
papillomavirus. This result, considered together with the OaPV3
peculiar cell tropism, places this virus in a new genus (tentatively
Dyokappa), according to the criteria needed to declare detection of a
novel genus among the papillomaviruses (Bernard et al., 2010).
Phylogenetic analyses based on a concatenated E1/E2/L2/L1 nucle-
otide sequence alignment of OaPV3 with 70 PV-types of the differentPV genera and species (Fig. 3) conﬁrmed OaPV3 as a novel close-to-
root papillomavirus weakly related to the Nu and Sigma genera..
Notably, papillomaviruses representative of the Nu and Sigma genera
were isolated from some skin carcinomas and premalignant keratoses
of human patients and from hyperplastic papillomatous regions of a
North American porcupine, respectively. Moreover, OaPV3 is actively
transcribed in tumors (Fig. 1D, E). However, the previously described
OaPV1 and OaPV2 were isolated only from sheep benign neoplasms
such as ﬁbropapillomas.
OaPV3 was successfully ampliﬁed from DNA extracted from
healthy skin of sheep belonging to geographically separated ﬂocks
(two of them with history of SCC), sampled in Sardinia (Italy). This
demonstrates that OaPV3 does not represent a strain adapted to a
single ﬂock, but it is most likely a virus well represented in sheep of
the Sarda breed. All skin samples generated constantly the same
sequence (with only one point mutation in one sample), and this can
be explained by considering that papillomaviruses are highly species
speciﬁc and that the Sarda is a relatively primitive sheep breed highly
selected for milk production. Therefore, a founder effect can be
speculated to be acting not only on Sardinian sheep but also on their
related papillomavirus genetic diversity. Our group recently used
endogenous integrated retroviruses (retrotypes) to investigate sheep
domestication events (Chessa et al., 2009), and demonstrated that
sheep differentiated on the basis of their “retrotype” and dispersed
across Eurasia and Africa via separate migratory episodes. It would be
357A. Alberti et al. / Virology 407 (2010) 352–359interesting to investigate more deeply sheep papillomavirus diversity
in order to assess its applicability to studies on host phylogeny and
phylogeography.
Concluding, it can be stated that OaPV3 is a new papillomavirus
with epithelial tropism, which is transcriptionally active in ovine SCCs
and is potentially related to tumor development, similarly to what has
been suggested for Beta papillomavirus and human SCC.
Conclusions
This paper represents a ﬁrst step towards the understanding of
oncogenic papillomavirus of sheep. The elucidation of OaPV3
oncogenic properties is hampered by the lack of diagnostic and
cellular biology tools, such as speciﬁc antibodies and a suitable cellular
model for ovine SCC. Remarkable epidemiologic similarities of this
condition have been observed to exist in sheep and humans living in
the same tropical environment (Ladds and Daniels, 1982). Likewise,
the pathological features of hyperkeratoses in sheep resemble solar
keratoses in man, and the same applies to more advanced lesions in
these species. Therefore, further studies are welcomed to clarify the
role of OaPV3 in precancerous skin lesions and in tumor progression,
and to establish a suitable animal model for human SCC.
Materials and methods
Origin of the samples
Biopsies were obtained from 4 sheep reared in 4 geographically
separated ﬂocks (A, B, C, D) located in Sardinia (Italy), and showing
lesions macroscopically indicative of SCC. Full-thickness biopsies of
each type of lesion and adjacent normal skin were taken. One set of
biopsies was ﬁxed in 10% neutral-buffered formalin, embedded in
parafﬁn, and sectioned to 4–6 mm slices. Adjacent slices were
mounted onto glass slides and alternatively stained with haematox-
ylin and eosin (H&E) for light microscopy, or used for in situ
hybridization (ISH) experiments. A second set of tissues was kept
at −80 °C until nucleic acids extraction. Skin samples of the same
locations were also collected from healthy sheep (n=40) of ﬂocks C
and D, and of ﬂocks E and F (2 distinct ﬂocks located in Sardinia where
sheep papillomatosis was observed but SCC was never recorded). Ten
sheep were sampled from each ﬂock. Skin samples were obtained by
scraping healthy sheep skin with a cover glass slide several times. The
cover glass slides where then saved in a 50-ml falcon tube and stored
at −20 °C until DNA extraction.
Nucleic acids extraction and multiply primed rolling-circle ampliﬁcation
DNA was extracted from tumors (20 mg) using the DNeasy blood
and tissue kit (Qiagen. Jesi, Italy), following vendor recommendations
for tissue samples. The same procedure was used for extracting DNA
from the 40 skin samples obtained from healthy sheep. RNA was
extracted from tumors previously disrupted with a tissuelyser
(Tissuelyser II; Qiagen, Iesi, Italy), by using the MagMax™ viral RNA
isolation kit and a MagMax Express automatic nucleic acid extractor
(Applied Biosystem, Monza. Italy), or alternatively the RNeasy micro
kit (Qiagen, Jesi, Italy). Sheep liver tissue samples were coupled to
each of the tumor and skin samples during nucleic acids extractions,
as a negative control. Rolling Circle Ampliﬁcation (RCA) (GE
Healthcare, Milano, Italy) combined with restriction enzyme analyses
were used in order to establish the presence of papillomavirus
genomes in tumors. RCA was performed using the TempliPhi 100
Ampliﬁcation kit (GE Healthcare, Milano, Italy), following protocols
recently optimized for ampliﬁcation of papillomaviral complete
genomes (Rector et al., 2004; Van Doorslaer et al., 2006). Shortly,
5 μl of tumor DNA extraction were mixed with 10 μl of TempliPhi
sample buffer and subsequently heated for 3 min at 95 °C, thentransferred into an ice-bucket. Ten microliters of TempliPhi reaction
buffer containing salts and deoxynucleotides (dNTPs), 0.4 μl of
TempliPhi enzyme mix containing the phi 29 DNA polymerase and
random hexamers in 50% glycerol, and 450 mM of extra dNTPs per
sample were mixed and added to the cooled samples, and the
reactions were subsequently incubated overnight (approximately
20 h) at 30 °C. Eventually, the phi 29 DNA polymerase was inactivated
at 65 °C for 10 min. After digestion with a restriction enzyme panel
(Table S2), the products were run on a 0.8% agarose gel to check for
the presence of a DNA band consistent with full-length papillomaviral
genomes, or multiple bands with sizes adding up to this length.
OaPV3 genome cloning, sequencing, sequence alignments, and
phylogenetic analyses
A 7.4-kb DNA fragment obtained by digesting RCA products with
SacI was cloned into pUC19 (Invitrogen, Milano, Italy) to generate
pUC19/OaPV3. Brieﬂy, 10 μl of the RCA product were digested with
100 units of SacI overnight and run on a 0.8% agarose gel, after which
the fragment was extracted by using the QIAquick Gel Extraction Kit
(Qiagen, Jesi, Italy). The fragment was then ligated into the pUC19
vector that was previously cut with SacI and dephosphorylated, by
using the Rapid DNA Dephos & Ligation Kit (Roche, Milano, Italy).
Ligation product was used to transform One Shot MAX Efﬁciency
DH5Alpha™-T1R competent cells (Invitrogen, Milano, Italy). Bacteria
were incubated for blue-white colony screening on agar plates
containing X-gal, and white colonies were checked by SacI digestion
of miniprep DNA. One clone containing the 7.4 kb DNA fragment was
selected. The complete genome of the Ovis aries Papillomavirus type 3
(OaPV3)was determined by primer-walking sequencing of the cloned
DNA fragment, starting from the universal primers sites in the
multiple cloning site of pUC19. Sequencing was performed on an ABI
Prism 3100 Genetic Analyzer (Perkin-Elmer Applied Biosystems,
Foster City, CA, USA). Electropherograms were inspected and edited
with Chromas 2.2 (Technelysium, Helensvale, Australia), and contigs
were prepared using SeqMan II (DNASTAR, Madison, WI, USA). Two
primers (OaPV3/F 5' GACACGTATATGCGGAATGC 3', OaPV3/R 5'
GCTAACAGAATCAACAGGAG 3') surrounding the SacI site were
designed based on the OaPV3 sequence available at that point of the
study. Primers OaPV3/F and OaPV3/R were used to exclude the
presence of two or more adjacent SacI sites in the OaPV3 genome,
potentially generating small DNA fragments not detectable in agarose
gel electrophoresis after digestion of the RCA product, and therefore
hampering the full length cloning of OaPV3 genome. This was done by
amplifying 892 base pairs from both a tumor DNA extraction and from
an undigested RCA product obtained from the same DNA sample.
Amplicons were routinely cloned into pCDNA3.1 using the topoTA
cloning kit (Invitrogen, Milano, Italy) following vendor recommen-
dation. For each of the two amplicons, three clones were selected after
transformation of E. coli DH5 alpha and sequenced for comparison.
The nucleotide sequence of the OaPV3 genome was deposited in
GenBank by using the National Center for Biotechnology Information
(NCBI, Bethesda, MD) BankIt v3.0 submission tool (http://www3.
ncbi.nlm.nih.gov/BankIt/) under accession number FJ796965. Predic-
tion of open reading frames (ORFs) was performed using the ORF
Finder tool on the NCBI server of the National Institutes of Health
(http://www.ncbi.nlm.nih.gov/gorf.html). The molecular weight of
the putative proteins was calculated using the ExPASy (Expert Protein
Analysis System) Compute pI/Mw tool (http://www.expasy.org/
tools/pi_tool.html). Pairwise sequence alignments and sequences
similarities were calculated using the ClustalW (Thompson et al.,
1994) and the identity matrix options of Bioedit (Hall, 1999),
respectively. For multiple nucleotide sequence alignments, the
sequences of OaPV3 and 70 other PVs were imported in DAMBE
version 4.2.7 (Xia and Xie, 2001), aligned at the amino acid level using
ClustalW, after which the nucleotide sequences were aligned
358 A. Alberti et al. / Virology 407 (2010) 352–359according to the aligned amino acid sequences. Also, alternative
alignments were generated by omitting the third codon positions.
This was done separately for the different ORFs, and the unambigu-
ously alignable parts of the E1, E2, L2, and L1 ORFs were pasted
together in one compiled alignment. Genetic distances among the
operational taxonomic units (OTUs) were computed as percent of
total nucleotide differences or by the Kimura 2-parameters method
using MEGA version 2.1 (Kumar et al., 2001), and were used to
construct neighbor-joining (NJ) trees (Saitou and Nei, 1987).
Statistical support for internal branches of the trees was evaluated
by bootstrapping (Felsenstein, 1985). Maximum parsimony (MP)
trees and consensus values were generated using the same software.
Trees were edited using NJplot (Perriere and Gouy, 1996) and
Treeview v. 1.5.2 (Page, 1996).
In situ hybridization and immunohistochemistry
The PCR DIG Probe Synthesis Kit (Roche, Milano, Italy) was used to
generate two digoxigenin-labeled probes by polymerase chain
reaction. For each of the two probes a 50 μl reaction was set up by
mixing 5 μl of PCR DIG Probe Synthesis Mix (containing 200 μM of
each dNTP and 70 μM DIGdUTP) with 5 μl of 10× PCR buffer
containing MgCl2, 0.75 μl of enzyme mix, 29.25 μl water, 5 μl
(100 pg) of pUC19/OaPV3, and 10 μl of the appropriate primers mix.
Digoxigenin labeled and unlabeled 151-bp-long E6 probes were
generated by using primers OaPV3/E6F (5' AAGCCCTCGTACAA-
TAGCTG 3') and OaPV3/E6R (5' GCCAAATCTCCAGAGTAAAGC 3').
Digoxigenin labeled and unlabeled 127-bp-long L1 probes were
obtained with primers OaPV3/L1F (5' AACTGGACTTGTCTTCCATG 3')
and OaPV3/L1R (5' AAAGACTCGGTATTGGGAGG 3'). PCR proﬁles were
designed following the manufacturer's instructions for probe synthe-
sis. Two unlabeled probes were generated by using the same protocol,
without digoxigenin incorporation in the PCR mix. Both digoxigenin
labeled and unlabeled probes were used (individually) for in situ
hybridization (ISH) experiments. Brieﬂy, parafﬁn embedded tissue
sections mounted onto positively charged glass slides were incubated
at 55 °C for 1 h, deparafﬁnized in changes of xylene, and rehydrated in
decreasing concentrations of ethanol. The sections were placed in
Tris-buffered saline (TBS) at 37 °C for 5 min, treated with pepsin, and
rinsed in TBS. After rinsing in distilled water, sections were
dehydrated in increasing concentrations of ethanol and air dried.
Slides were treated with 200 μl of pre-hybridization solution (100 μl
molecular grade Fluka hybridization solution II, 86 μl formamide, 14 μl
mQ water) and incubated at 37 °C for 2 h in humidity chamber. After
removing the Pre-hybridization solution, slides were covered with a
cover glass, treated with 200 μl of hybridization solution (obtained by
adding 5 μl of 40 ng/ml denatured molecular probe to 100 μl
molecular grade Fluka hybridization solution II, 86 μl formamide,
9 μl mQ water), placed at 95 °C for 8 min, and then transferred in
humidity chamber and incubated overnight. The following day the
unhybridized probes were removed by washing tissue slides twice
with TBS (5 min per wash) and then treated with decreasing
concentrations of Sigma-Aldrich (Italy) molecular biology grade
SSPE (5 minutes washes at 25 °C with 2×, 1×, 0.5× SSPE, 30 min
wash at 50 °C with SSPE 0.1× and BSA 0.2%, 5 min wash at 25 °C with
SSPE 0.1× and BSA 0.2%). Tissues slides were then washed for ﬁve
minutes with buffer I (0.1 M Tris, 0.15 M NaCl; pH 7.6). Non-speciﬁc
endogenous alkaline phosphatase was blocked with normal rabbit
serum (NRS, Sigma-Aldrich, Italy) by incubating slides with 200 μl of
blocking solution (20 μl NRS, 3.1 μl of 0.3% Triton X100; 980 μl buffer I)
in humidity chamber at room temperature for 45 min. For detection of
the digoxigenin-labeled hybrids, slides were incubated for 2 h with
1:25 diluted anti-digoxigenin-AP Fab fragments (Sigma-Aldrich, Italy)
at room temperature. Slides were rinsed twice and incubated for
50 min at 37 °C in the dark with 5-bromo-4-chloro-3-indolyl
phosphate (BCIP) and 4-nitro blue tetrazolium chloride (NBT). Colordevelopment was stopped with TE buffer (pH 8.0). Slides were
mounted with Top-Water mount (W. Pabisch SpA, Italy), and
photographed with a light microscope. After ISH, slides were
submitted to immunohistochemistry and incubated with anti-pan-
cytokeratin antibodies (anti-human pan cytokeratin AE1/AE3, Dako,
Denmark) diluted 1:300. Sections were treated with preformed
streptavidin biotin complex, and diamino-benzidine chromogen
(DAB, LAB Probe Kit, Biomeda Corporation, CA), following the vendor
recommendations. Slides were then washed in PBS, dehydrated
through dH2O and graded alcohols, cleared with xylene, andmounted
using Eukitt (Bio Optica Milano SpA, Italy) mounting media.
Detection of OaPV3 DNA in healthy sheep skin samples
Primers OVPV3/L1F and OVPV3/L1R, targeting 127 bp of the
OAPV3 L1 gene, were designed to and used to detect speciﬁc OaPV3
DNA in 40 sheep skin DNA extractions. Brieﬂy, 5 μl of skin DNA
extractions (100 ng) were used in a typical PCR reaction, containing
200 μM dNTPs, 1 μM primers, and 1.25 U of GoTAQ (Promega, Milano,
Italy). PCR proﬁle and mix were designed according to the manufac-
turer's instructions for GoTAQ. Skin DNA samples were run in
triplicate and coupled with the sheep liver DNA samples used as
negative controls for extractions. PCR was repeated three times.
Amplicons were routinely cloned into pCR2.1TOPO (Invitrogen,
Milano, Italy) and automatically sequenced.
Detection of OaPV3 early transcripts in ovine SCC
Complementary DNA was obtained from 2 ovine SCCs and from
liver RNA extractions by using the SuperScript® First-Strand
Synthesis System for RT-PCR, following the vendor instructions
(Invitrogen, Milano, Italy). Either random hexamers, primer OaPV3/
E6/START: 5' ATGGAGGGAAGCCCTCGTAC 3', and primer OaPV3/E7/
START: 5' ATGCGTGGTCAGCAGCCCAC 3', were separately used to
prime ﬁrst-strand synthesis. The presence of early transcripts in
tumors was investigated by using the cDNAs obtained as templates for
two distinct PCR assays, based on the use of primers pairs (OaPV3/E6/
START: 5' ATGGAGGGAAGCCCTCGTAC 3' and OaPV3/E6/STOP: 5'
TCAGGGAGTGTGGGCTGCTG 3' for E6; OaPV3/E7/START: 5'
ATGCGTGGTCAGCAGCCCAC 3' and OaPV3/E7/STOP: 5' CTATGCAG-
CACACGGCGGAC 3' for E7). PCR proﬁles and mixes were set up
according to manufacturer's recommendations for the polymerase
used (GoTAQ Promega, Italy). As an additional control, aliquots of
DNase-treated RNA extractions were subjected to PCR in order to rule
out the presence of residual DNA in samples. PCRs were repeated 3
times starting from 3 replicates of independently-obtained cDNA
batches. PCR products were routinely cloned and sequenced.
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